Precigen
PGEN
#5241
Rank
ยฃ1.26 B
Marketcap
ยฃ3.52
Share price
5.82%
Change (1 day)
15.63%
Change (1 year)

P/E ratio for Precigen (PGEN)

P/E ratio as of November 2026 (TTM): -4.26

According to Precigen's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.26126. At the end of 2022 the company had a P/E ratio of 10.9.

P/E ratio history for Precigen from 2013 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202210.9-237.54%
2021-7.89-21.06%
2020-10.0281.39%
2019-2.6256.36%
2018-1.68-85.73%
2017-11.8-23.57%
2016-15.4-62.76%
2015-41.324.52%
2014-33.21289.03%
2013-2.39

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Organovo
ONVO
-0.1771-95.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-2.69-36.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-7.16 68.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-9.64 126.19% Jersey

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.